Coronary stent thrombosis prevention by platelet aggregation test
Автор: Gitelson D.G., Faibushevich A.G., Maximkin D.A., Veretnik G.I., Vasiliev A.E., Gitelson E.A., Danishian K.I.
Журнал: Вестник Национального медико-хирургического центра им. Н.И. Пирогова @vestnik-pirogov-center
Рубрика: Клинические наблюдения
Статья в выпуске: 4 т.14, 2019 года.
Бесплатный доступ
The coronary artery stenting is a common and effective endovascular treatment for various forms of coronary artery disease (CAD). In most cases prescribed dual antiplatelet therapy (DAPT) helps prevent stent thrombosis (ST). However, the effectiveness of DAPT is rarely monitored. Despite there are 0.6-2 chances in the first year of having ST with high mortality rate after coronary artery stenting. We have seen several cases of acute ST in our practice. Here is a clinical observation.
Platelet aggregation, antiplatelet therapy, coronary artery stenting, coronary artery disease
Короткий адрес: https://sciup.org/140249322
IDR: 140249322 | DOI: 10.25881/BPNMSC.2020.60.92.026
